Resource Library
Showing 1 to 10 of 36 results
Image
Tiffany Woodworth shares her story of receiving a Hodgkin lymphoma diagnosis as a young adult, and the supports that she received during her experience.
Image
Dr. Jacqueline Costello talks about the basics of Diffuse large B-cell lymphoma (DLBCL), diagnosis, treatment, side effects, and research for DLBCL.
Image
Bob Sisler has been in remission from Angioimmunoblastic T-cell lymphoma, a type of Peripheral T-cell lymphoma, since 2015. Bob shares with us his personal experience with diagnosis, treatments, and life after blood cancer. As a Peer Support Volunteer, Bob gives back to the blood cancer community through the LLSC’s First Connection program.
Image
Paul Davis speaks to us about his experience with Diffuse large B-cell lymphoma (DLBCL) and an underlying Follicular Lymphoma.
Image
In this special AYA episode, guest host Montana Skurka connects with Amanda Saunders, who 13 months after having a heart transplant was diagnosed with post-transplant lymphoproliferative disorder (PTLD). The two discuss what life is like living with a rare blood cancer while completing university and living through a pandemic.
Image
When Darren Bessette was re-diagnosed with diffuse large B-cell lymphoma (DLBCL) in 2019, it was more difficult to treat. Darren says he was fortunate to get access to a "revolutionary" new treatment through a clinical trial. Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells to fight cancer by changing them…
Image
When Ron Ternoway was diagnosed with a rare blood cancer called Waldenstrom macroglobulinemia (WM), he tracked down as much information as he could so he could be, as he describes it, a full partner is his treatment.
Image
Everything was going right for Al Pritchard - he had a young family, a good career and was a healthy athlete. So it came as a shock to be diagnosed with anaplastic large cell lymphoma. His experience taught him a few valuable lessons.
Image
Mayra Husic shares her experience with Follicular Lymphoma.
Image
“The majority of people with DLBCL will be cured with their first treatment – so that's a success story,” says Dr. John Kuruvilla, working as a hematologist-oncologist for 20 years including as a researcher in DLBCL, which is the largest form of non-Hodgkin lymphoma.
“Researchers are now focused on maintaining an excellent cure rate and…
“Researchers are now focused on maintaining an excellent cure rate and…